Omeros | Umsatzkosten





Umsatzkosten Veränderung Datum
Adma Biologics USD 58.64M 3.88M 2025-09
Alnylam Pharmaceuticals USD 200.15M 57.2M 2025-09
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Cytokinetics USD 112.55M 12.71M 2025-06
Dynavax Technologies USD 14.4M 368K 2025-09
Gilead Sciences USD 1.57B 68M 2025-09
Heron Therapeutics USD 9.46M 1.61M 2024-09
Insmed USD 30.9M 1.56M 2025-09
Knight Therapeutics CAD 47.25M 990K 2024-09
MacroGenics USD 44.3M 5.4M 2025-09
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 48.6M 6.59M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
Rockwell Medical USD 21.28M 1.67M 2024-06
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
United Therapeutics USD 100.9M 74.3M 2025-09
Vertex Pharmaceuticals USD 414.8M 7.3M 2025-09
Xoma 116K 112.7K 2024-06


Omeros Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.